Yubo International Biotech Ltd (YBGJ) — 10-Q Filings

10-Q Filings (6)

• Yubo Biotech Narrows Losses Amidst Zero Revenue, Asset Decline — Nov 14, 2025 Risk: high
  Yubo International Biotech Ltd (YBGJ) reported a net loss of $310,152 for the three months ended September 30, 2025, a significant improvement from the $621,053
• Yubo Biotech's Sales Vanish, Losses Narrow Amidst Asset Decline — Aug 13, 2025 Risk: high
  Yubo International Biotech Ltd (YBGJ) reported a net loss of $592,136 for the six months ended June 30, 2025, a significant improvement from the $1,007,853 net
• Yubo Biotech Q1 2025: Assets $119.8M, Net Income $1.2B — May 14, 2025 Risk: medium
  Yubo International Biotech Ltd. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $119,816,343 and total liabilities of
• Yubo International Biotech Ltd. Files Q3 2024 10-Q — Nov 13, 2024 Risk: low
  Yubo International Biotech Ltd. filed its 10-Q for the period ending September 30, 2024. The company, incorporated in NY, operates in the electromedical and ele
• Yubo International Biotech Ltd. Files Q2 2024 10-Q — Aug 19, 2024 Risk: medium
  Yubo International Biotech Ltd. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as MAGNA LAB INC, is incorporated in New York an
• Yubo International Biotech Ltd Files Q1 2024 10-Q — May 20, 2024 Risk: medium
  Yubo International Biotech Ltd filed its Q1 2024 10-Q report on May 20, 2024, for the period ending March 31, 2024. The company, incorporated in NY, operates in

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX